×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Your Source for Life Science Knowledge
DIA NOW is your comprehensive, personalized resource for the latest trends and up-to-the-minute updates on a wide variety of critical issues in the Life Sciences arena.
Access recorded sessions from the more than 60 global meetings taking place around the world annually, and breaking news and analysis from DIA’s publishing group.
Learn more about DIA NOW
DIA NOW Enterprise
For groups of 50 or more
Keep your staff current on the latest trends impacting drug development, regulation, and health policy across a wide variety of topic areas.
DIA NOW In Focus
For individuals
All the power, depth and immediacy of DIA NOW Enterprise, but focused exclusively on Pharmacovigilance and Clinical Safety.
-
Stay Ahead
- Latest Breaking News
- Trends and Developments
- Key Players in the Field
- Global Perspective
-
Educate
- Deep Content on Dozens of Important Topics
- Group Learning
- Powerful Search
- Multimedia Presentation
-
Gain Insights
- Analysis and Synthesis
- Engaging Conversations and Perspectives
- Challenging Questions
- Provocative Hypotheses
Watch DIA NOW in Action
Pricing varies based on number of users. Contact us for more information.
Coverage and Content
Access thousands of videos, podcasts and publications spanning the drug development life cycle.
Featured Content Previews
Clinical Development & Operations
FDARA Section 504 eliminated the orphan exemption for pediatric studies for cancer drugs and instead empowers the FDA to require pediatric assessments of new therapies.
Patient Engagement
Patient engagement initiatives are shown to increase chances of regulatory approval and accelerate development timelines.
Clinical Development & Operations
Clinical Safety & Pharmacovigilance
Data & Data Standards
Medical Affairs & Scientific Communications
Patient Engagement
Preclinical & Early Phase Research
Project Management & Strategic Planning
Quality Assurance, Control & CMC
Rare Disease & Special Populations
Regulatory
Statistics
